June 01, 2020: "Prevention and treatment services for noncommunicable diseases (NCDs) have been severely disrupted since the COVID-19 pandemic began, according to a WHO...
June 01, 2020: "AstraZeneca and MSD announced that Lynparza (olaparib) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line maintenance treatment...
June 1, 2020:Â "Hutchison China MediTech Limited announces that it has held its pre-New Drug Application meeting with the U.S.FDA for surufatinib for the treatment...
June 1, 2020:Â "Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight...
June 1, 2020: Eli Lilly and Company announced that U.S.FDA has approved a supplemental Biologics License Application (sBLA) for Taltz® (ixekizumab) injection 80 mg/mL for the...
June 01, 2020: "CytoDyn announced that it has filed with the U.S. FDA a request seeking Priority Review designation for the Company’s Biologics License...